Eli Lilly Has Ability to Grow Revenue: CEO Lechleither

John Lechleiter, chief executive officer of Eli Lilly & Co., talks about the company's experimental Alzheimer’s drug, growth strategy and drug pipeline. Lechleiter speaks with Tom Keene and Brendan Greeley on Bloomberg Television's "Surveillance." (Source: Bloomberg)

Trump to Address Afghanistan Policy in Primetime
41:44 - Bloomberg’s Kevin Cirilli previews a primetime speech for President Trump on Afghanistan and discusses the administration sans Steve Bannon. He speaks with David Gura on "Bloomberg Surveillance." (Source: Bloomberg)
  • Maersk CEO Says Selling Oil and Gas Unit Was Best Option
  • Merkel Stands by Her Decision to Open German Borders
  • Aberdeen's Athey Says U.S. Dollar Is Oversold